Abstract
Background and Aims: To evaluate the rate of control of LDL-C, following the 2019 ESC/EAS guidelines, in a diabetic patient cohort treated according to 2016 guidelines if ezetimibe was added to the actual treament
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
